Hypera SA 2021 AR2
The report highlights Hypera Pharma's transformational year in 2021, marked by a 45.2% expansion in Net Revenue and the successful acquisition of major brands like Takeda, Simple Organic, and Bioage. The company significantly increased its production capacity in Anápolis and invested BRL 331 million in Research and Development. On the sustainability front, Hypera Pharma advanced its ESG strategy, receiving the GHG Protocol Gold Seal and the Seriema Trophy for its Water Plan. Additionally, the company committed BRL 11 million to the Juntos pelo Araguaia project for forest restoration and water conservation.
Company: Hypera SA
Sector: Manufacturing
Country: Brazil
Year: 2021
Type: AR2
Pages: 107
Back to company
Hypera SA
Annual Report
The report highlights Hypera Pharma's transformational year in 2021, marked by a 45.2% expansion in Net Revenue and the successful acquisition of major brands like Takeda, Simple Organic, and Bioage. The company significantly increased its production capacity in Anápolis and invested BRL 331 million in Research and Development. On the sustainability front, Hypera Pharma advanced its ESG strategy, receiving the GHG Protocol Gold Seal and the Seriema Trophy for its Water Plan. Additionally, the company committed BRL 11 million to the Juntos pelo Araguaia project for forest restoration and water conservation.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees